menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

CDC - Lyme Disease: Challenges and Innovations, Part 3

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.

    Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.

    This is Part 3 of a lecture in three parts.

    Part 1 >>

    Part 2 >>

    To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

    And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline

    CDC's participation in the activity is not meant to serve as an endorsement of ReachMD, XM Satellite Radio, or any particular individual or product.

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.

    Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.

    This is Part 3 of a lecture in three parts.

    Part 1 >>

    Part 2 >>

    To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

    And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline

    CDC's participation in the activity is not meant to serve as an endorsement of ReachMD, XM Satellite Radio, or any particular individual or product.

     

Facebook Comments

Schedule29 Mar 2024